USPH (US Physical Therapy) ROE %: -3.66% (As of Mar. 2026)


USPH US Physical Therapy Inc USPH
77 GF Score
Price $66.21
GF Value $107.60
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is US Physical Therapy ROE %?

US Physical Therapy USPH +4.27% 77 ROE % is -3.66% as of Mar. 2026. GuruFocus rates USPH with a GF Score™ of 77/100 and a GF Value™ of $107.60 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 628 Healthcare Providers & Services companies, US Physical Therapy ranks worse than 69.59% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. US Physical Therapy's annualized net income for the quarter that ended in Mar. 2026 was $-17.3 Mil. US Physical Therapy's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $472.7 Mil. Therefore, US Physical Therapy's annualized ROE % for the quarter that ended in Mar. 2026 was -3.66%.

The historical rank and industry rank for US Physical Therapy's ROE % or its related term are showing as below:

USPH' s ROE % Range Over the Past 10 Years
Min: -0.42   Med: 9.49   Max: 12.34
Current: -0.42

During the past 13 years, US Physical Therapy's highest ROE % was 12.34%. The lowest was -0.42%. And the median was 9.49%.

USPH's ROE % is ranked worse than
69.59% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs USPH: -0.42

US Physical Therapy  (NYSE:USPH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-17.324/472.7035
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-17.324 / 793.144)*(793.144 / 1223.0335)*(1223.0335 / 472.7035)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2.18 %*0.6485*2.5873
=ROA %*Equity Multiplier
=-1.41 %*2.5873
=-3.66 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-17.324/472.7035
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-17.324 / 42.252) * (42.252 / 57.912) * (57.912 / 793.144) * (793.144 / 1223.0335) * (1223.0335 / 472.7035)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= -0.41 * 0.7296 * 7.3 % * 0.6485 * 2.5873
=-3.66 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


US Physical Therapy ROE % Related Terms


US Physical Therapy ROE % Historical Data

* Premium members only.

The historical data trend for US Physical Therapy's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Physical Therapy ROE % Chart

US Physical Therapy Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.73 9.25 3.71 5.48 3.12

US Physical Therapy Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.39 6.08 4.16 -8.61 -3.66

USPH vs INNV, NUTX, AMN: ROE % Comparison

For the Medical Care Facilities subindustry, US Physical Therapy's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Physical Therapy ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's ROE % distribution charts can be found below:

* The bar in red indicates where US Physical Therapy's ROE % falls into.


USPH
77GF Score
US Physical Therapy Inc USPH
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Physical Therapy ROE % Calculation

US Physical Therapy's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=15.062/( (488.929+476.432)/ 2 )
=15.062/482.6805
=3.12 %

US Physical Therapy's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-17.324/( (476.432+468.975)/ 2 )
=-17.324/472.7035
=-3.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -3.66% mean?
US Physical Therapy (USPH) has a ROE % of -3.66% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on US Physical Therapy and its competitors. According to the industry distribution chart, US Physical Therapy ranks #437 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 69.6%.
Is US Physical Therapy's ROE % too high?
US Physical Therapy's current ROE % is -3.66%. Based on the distribution chart, US Physical Therapy ranks #437 out of 628 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, US Physical Therapy has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does US Physical Therapy's ROE % compare to INNV and NUTX?
According to the Healthcare Providers & Services industry distribution chart, US Physical Therapy ranks #437 out of 628 companies for ROE %. This places US Physical Therapy in the lower half of its industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on US Physical Therapy and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. US Physical Therapy's current ROE % is -3.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Physical Therapy stock overvalued right now?
Based on GuruFocus' analysis, US Physical Therapy (USPH) is currently considered Significantly Undervalued. The stock's GF Value™ is $107.60, compared to a current price of $66.21 — trading 38.5% below its estimated fair value. The current ROE % is -3.66%. US Physical Therapy's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For US Physical Therapy (USPH), the current ROE % is -3.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is US Physical Therapy (USPH) Overvalued in 2026?

Based on GuruFocus' analysis, US Physical Therapy stock appears to be undervalued. The current stock price of $66.21 is trading 38.5% below its estimated GF Value™ of $107.60. GuruFocus considers US Physical Therapy to be Significantly Undervalued.

Key valuation signals for USPH:

  • ROE %: -3.66%
  • GF Value™: $107.60 vs. price of $66.21 (38.5% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the USPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


US Physical Therapy Business Description

Address 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
77GF Score

Get the complete analysis for USPH

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$66.21
Price
$107.60
GF Value